2016 VAM: 4816 - New Approaches to Induce Tolerance and Modify the Natural History of Allergic Diseases

This session takes a complete journey of 'other issues related to immunotherapy': from the immunological background of how we could try to influence immune deviation that leads to allergy, to the new routes of immunotherapy that have been successfull till now in trials with food allergic children, to end with new molecules with which to adminster immunotherapy: not only T-cell epitopes, but also B-cell epitopes that have shown very interesting data in latest trials.

AMA PRA Category 1 Credits™: 1.25
CE: 1.25

Credit must be claimed by May 31, 2018.  Any credit request on or after June 1, 2018 will be subject to an administrative fee.

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants will be able to:
1.  Identify new studies into alternatives to SCIT and SLIT and analyze trial results
2.  Investigate the immunological bases for allergy and determine how to influence them from very early inception onward
3.  Develop new methods of administration, including epicutaneous immunotherapy

Additional Information

AttachmentSize
PDF icon 2016 Annual Meeting Disclosures120.13 KB
Summary
Available credit: 
  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.
Course opens: 
05/31/2016
Course expires: 
05/31/2018
Cost:
$15.00
Part of: 
2016 Virtual Annual Meeting Recordings
Rating: 
0

Dr. Mubeccel Akdis, MD PhD, Swiss Institute of Allergy and Asthma Research, Davos, Switzerland
Relevant relationships: None

Dr. A. Wesley Burks, MD FAAAAI, University of North Carolina at Chapel Hill, Chapel Hill, NC
Relevant relationships: None

Prof. Rudolf Valenta, MD, Medical University of Vienna AKH, Wien, Austria
Relevant relationships: Consultant: Biomay AG Vienna, Austria, Thermofisher, Uppsala,Sweden, Fresenius Medical Care, Bad
Homburg, Germany. Thermofisher Uppsala (Ongoing),  Biomay Vienna (Ongoing), Fresenius Medical Care (Ongoing) and Austrian Science Fund FWF Research Grant.

Annual Meeting sessions and faculty were reviewed by members of the Practice Improvement Subcommittee.  Disclosures are located in the 2016 Annual Meeting Disclosures PDF. 

Available Credit

  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.

Price

Cost:
$15.00
Please login or register to take this course.

Required Hardware/software

Our system supports the two most recent versions of Safari, Google Chrome, and Firefox. Internet Explorer is not recommended.